Toshiharu Nagatsu

7PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsTraditional Chinese medicine and treatmentsNeurology and neuromuscular diseasesChiropracticCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 24, 2024
Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges.

Hirohisa Watanabe, Johannes M Dijkstra, Toshiharu Nagatsu

|Aug 28, 2023
Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.

Toshiharu Nagatsu

|Mar 20, 2023
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease.

Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe

|Apr 23, 2022
Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.

Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe

|Dec 10, 2021
Cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy (MT); comparison of three established psychotherapies and possible common neural mechanisms of psychotherapies.

Johannes M Dijkstra, Toshiharu Nagatsu

|Jan 29, 2020
Correction to: Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?

Toshiharu Nagatsu

Pageof 2

Frequent Collaborators

3 joint publications

Hirohisa Watanabe

2 joint publications

Akira Nakashima

2 joint publications

Shosuke Ito

2 joint publications

Kazumasa Wakamatsu